The University of Michigan Comprehensive Cancer Center — Ann Arbor, Michigan

The University of Michigan Comprehensive Cancer Center is a clinical research site located in Ann Arbor, Michigan, United States 48109.

Crixeo Health Trust Score: 78/100 (FAIR). This profile has not yet been claimed by the site owner.

The University of Michigan Comprehensive Cancer Center has participated in 22 clinical trials.

Therapeutic areas: Bladder Cancer, Prostate Cancer, Carcinoma, Hepatocellular.

Sponsors: University of Michigan Rogel Cancer Center, Tony Bekaii-Saab, Oncoimmune, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA).

Sponsor Feasibility Report

Trust Score: 78/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The University of Michigan Comprehensive Cancer Center?

The University of Michigan Comprehensive Cancer Center has a Crixeo Trust Score of 78/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The University of Michigan Comprehensive Cancer Center conducted?

The University of Michigan Comprehensive Cancer Center has 22 clinical trials on record. Their work covers Bladder Cancer, Prostate Cancer, Carcinoma, Hepatocellular.

Is The University of Michigan Comprehensive Cancer Center accredited by Crixeo Health?

Yes — The University of Michigan Comprehensive Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about The University of Michigan Comprehensive Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.